Delirium is a serious condition that causes confusion and disorientation. It can come on suddenly and may be triggered by ...

The common diabetes drug metformin works partly by excreting sugar from the bloodstream into the intestines, where gut ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

However, people using metformin for its FDA-approved use may lose weight as a side effect. The exact mechanism of why weight loss may occur is unclear. Unlike other diabetes medications ...

A new study from Northwestern University has found that two widely prescribed type 2 diabetes medications—sulfonylureas and ...

Type 2 diabetes is a common health condition that causes blood sugar levels to become too high but one vegetable could help ...

Generic versions of diabetes drug Empagliflozin launched in India, crashing prices by 80-90% on day one post-patent expiry.

Several domestic drug makers, including Mankind Pharma, have launched the diabetes drug Empagliflozin at significantly ...

Researchers have found in a new study that patients receiving a combination of metformin and SGLT2 inhibitors experienced a ...

Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.

According to the company's statement, these medications are designed to improve glycemic control in adults with Type 2 Diabetes while also reducing cardiovascular outcomes in the patients.

Alkem Laboratories launches generic empagliflozin in India as Empanorm, offering affordable treatment for diabetes and ...